COMP <GO>
KRMD vs STIM // FREE CASH FLOW YIELD
KORU Medical Systems Inc. (NASDAQ) VS. Neuronetics Inc. (NASDAQ) • 15-METRIC TALLY: KRMD 7
— STIM 3
▲ FREE CASH FLOW YIELD LEADER: KRMD
LAST: $3.05 (+2.01%) • MKT CAP: $138.1M
fcf-yield
0.31%
LAST: $2.06 (-8.44%) • MKT CAP: $171.4M
fcf-yield
-11.25%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRMD VS. STIM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRMD | STIM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | 48.50% | +13.80 | KRMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.70% | -35.00% | +6.30 | KRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 0.31% | -11.25% | +11.56 | KRMD | /fcf-yield <GO> |
| Operating Margin | -7.20% | -21.10% | +13.90 | KRMD | /operating-margins <GO> |
| Net Profit Margin | -6.40% | -26.10% | +19.70 | KRMD | /net-margins <GO> |
| Revenue Growth (YoY) | 22.20% | 99.20% | -77.00 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.05 | 0.20 | +7.85 | KRMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | KRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 49.7 | -5.20 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $138.1M | $171.4M | -$33.4M | STIM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRMD REV | STIM REV | KRMD GROSS % | STIM GROSS % | KRMD FCF | STIM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.1M | $149.2M | 62.3% | 48.5% | $462.4K | -$20.4M |
| FY 2024 | $33.6M | $74.9M | 63.4% | 72.3% | -$319.7K | -$31.0M |
| FY 2023 | $28.5M | $71.3M | — | — | -$4.9M | -$32.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRMD // BETA —
STIM // BETA —